Levetiracetam poisoning with acute kidney injury treated with hemodialysis: A case report

Medicine (Baltimore). 2022 Sep 30;101(39):e30884. doi: 10.1097/MD.0000000000030884.

Abstract

Introduction: Levetiracetam is a newer second-generation anticonvulsant for the treatment of generalized and partial seizure disorders. Common adverse effects are rhabdomyolysis and neuropsychiatric problems, such as somnolence, dizziness, and mood changes. The present report describes the first case, to our knowledge, of levetiracetam overdose resulting in acute kidney injury for which hemodialysis was required.

Patient concerns: A 51-year-old man presented with hypotension and disturbance of consciousness with subsequent development of oliguria and elevated creatinine. Based on his history of ingesting a large dose of levetiracetam and the course of the disease, he was considered to have been poisoned by levetiracetam.

Diagnosis: Acute kidney injury induced by levetiracetam poisoning.

Interventions/outcomes: Dialysis was performed for the rapidly progressing renal failure. His renal function improved, and he was weaned from dialysis and discharged home on the 19th day.

Conclusion: We should be aware of the possibility that severe renal function deterioration may occur in some patients with levetiracetam overdose. It is possible that clinicians underestimate the occurrence of this problem. In cases of acute renal failure in levetiracetam poisoning, induction of dialysis is beneficial.

Publication types

  • Case Reports

MeSH terms

  • Acute Kidney Injury* / chemically induced
  • Acute Kidney Injury* / therapy
  • Anticonvulsants / adverse effects
  • Creatinine
  • Drug Overdose*
  • Humans
  • Levetiracetam / adverse effects
  • Male
  • Middle Aged
  • Renal Dialysis

Substances

  • Anticonvulsants
  • Levetiracetam
  • Creatinine